ALIBREX Trademark Information

Cadex Genomics, Corp.

Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagen...

Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

This is a brand page for the ALIBREX trademark by Cadex Genomics, Corp.  in Redwood City, CA, 94063.

Write a review about a product or service associated with this ALIBREX trademark. Or, contact the owner Cadex Genomics, Corp. of the ALIBREX trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the ALIBREX trademark.

On Wednesday, February 13, 2019, a U.S. federal trademark registration was filed for ALIBREX. The USPTO has given the ALIBREX trademark serial number of 88299485. The current federal status of this trademark filing is PUBLISHED FOR OPPOSITION. The correspondent listed for ALIBREX is JAMES K. STRONSKI of CROWELL & MORING LLP, 590 MADISON AVENUE, 20th Floor, NEW YORK NY 10022 . The ALIBREX trademark is filed in the category of Computer & Software Services & Scientific Services , Medical, Beauty & Agricultural Services , Pharmaceutical Products . The description provided to the USPTO for ALIBREX is Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy.

Word mark: ALIBREX
Status/Status Date:
PUBLISHED FOR OPPOSITION
12/10/2019
Serial Number: 88299485
Filing Date: 2/13/2019
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 12/10/2019
Last Applicant/Owner: Cadex Genomics, Corp.
Redwood City, CA 94063
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
CROWELL & MORING LLP
590 MADISON AVENUE, 20th Floor
NEW YORK NY 10022

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your ALIBREX trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $199/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
12/10/2019
PUBLISHED FOR OPPOSITION
Correspondent Search:

JAMES K. STRONSKI is a correspondent of ALIBREX trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: